Andre Efira
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Sickle cell disease and COVID-19: Atypical presentations and favorable outcomes.
Journal: EJHaem
Published: July 06, 2020
Evaluation of Cardiac Function in Patients with Sickle Cell Disease with Left Ventricular Global Longitudinal Strain.
Journal: Journal of translational internal medicine
Published: May 22, 2020
Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease.
Journal: PloS one
Published: July 10, 2019
Added value of speckle tracking in the evaluation of cardiac function in patients with sickle cell disease.
Journal: British journal of haematology
Published: June 21, 2018
Sweet's syndrome induced by pegfilgrastim during a myelodysplastic syndrome AREB2: A case report
Journal: La Revue de medecine interne
Published: May 27, 2018
The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 12, 2018
Tamoxifen induced thromboembolic events in breast cancer. Some possible mechanisms
Journal: Revue medicale de Bruxelles
Published: January 11, 2018
Effect of N-acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial.
Journal: British journal of haematology
Published: June 24, 2017
The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study.
Journal: Clinical biochemistry
Published: August 31, 2016
Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment.
Journal: Pediatric blood & cancer
Published: January 14, 2015
Sickle cell disease patients, sickness and medical accompanying questioning related to specific adolescent period
Journal: Revue medicale de Bruxelles
Published: June 10, 2014
Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes.
Journal: Leukemia research
Published: November 17, 2013
Last Updated: 09/26/2026